A growing body of evidence suggests that antiphospholipid antibodies (aPL) can predispose to SCH formation by promoting a pro-thrombotic and pro-inflammatory state at the decidual-placental interface (5, 6). The gene discussed is FASLG; the disease is spindle cell hemangioma.